BioSpace News Archive

Osmometers Market: North America Leads, But Opportunities Abound in Developing Countries

Transparency Market Research has published a new report on the osmometers market for the forecast period of 2019–2027. According to the report, the global osmometers market was valued at ~US$ 64 Mn in 2018, and is projected to expand at a CAGR of ~3% from 2019 to 2027.

April 30, 2020
·
4 min read
Gonorrhea Therapeutics Market - High Scope of Advancement with Curative Approach

Transparency Market Research has published a new report on the gonorrhea therapeutics market for the forecast period of 2019–2027.

April 30, 2020
·
6 min read
Hepatorenal Syndrome Treatment Market: Exponential Growth in Therapeutics Boosts Growth of Market

Transparency Market Research has published a new report on the hepatorenal syndrome treatment market for the forecast period of 2019–2027.

April 30, 2020
·
4 min read
Hemostasis Valves Market: Stakeholders Innovate on Hemostasis Valves for Future Therapeutic Catheter Development Projects

Transparency Market Research has published a new report on the global hemostasis valves market for the forecast period of 2019–2027.

April 30, 2020
·
4 min read
Companion Animal Diagnostics Market : In-house Disease Testing of Pets to Gain Popularity

Transparency Market Research has published a new report on the companion animal diagnostics market for the forecast period of 2019–2027.

April 30, 2020
·
5 min read
Policy

Medivir Receives Positive Opinion on Orphan Medicinal Drug Designation by the European Medicines Agency for MIV-818

Medivir AB announced that it has received positive opinion from the Committee for Orphan Medicinal Products on orphan medicinal product designation in the EU for MIV-818 for the treatment of patients with hepatocellular carcinoma, the most common type of primary liver cancer.

April 30, 2020
·
2 min read
Deals

Replimune to Provide Data Update on June 3, 2020

Replimune Group Inc. announced it will host a conference call to provide updated data from patients with melanoma and non-melanoma skin cancers treated with RP1 combined with Opdivo® in its ongoing Phase 1/2 clinical trial.

April 30, 2020
·
1 min read
Deals

AcelRx Announces DSUVIA® Milestone C Approval and Provides Business Update

AcelRx Pharmaceuticals, Inc. announced that DSUVIA achieved Milestone C approval, a decision that clears the path for DSUVIA to be included in military sets, kits and outfits.

April 30, 2020
·
12 min read
Business

Novocure Reports First Quarter 2020 Financial Results and Provides Company Update

Quarterly net revenues of $101.8 million, representing 39 percent growth versus the first quarter 2019 and 3 percent growth versus the fourth quarter 2019

April 30, 2020
·
10 min read
Deals

Bio-Techne Declares Dividend - April 30, 2020

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2020.

April 30, 2020
·
1 min read